"This is wonderful news for UNLV and the University of Nevada School of Medicine," said Nevada Senator Harry Reid. "They led a collaborative effort to develop a proposal to improve research and medical care across Nevada and parts of the West. I strongly supported this effort and urged the National Institutes of Health to select this grant. These federal grant funds will help Nevada and our universities, research and medical facilities better address some of our most difficult health care challenges."
Though most CTR-IN universities have successful programs in basic science, they lack capacity in clinical or bench-to-bedside research -- what the NIH refers to as translational research -- and have limited resources to support faculty conducting this type of work. Only three partner institutions have medical schools and the two outside of Nevada -- the Universities of New Mexico and Hawaii -- have NIH-funded research centers to provide additional support to CTR-IN partners. With this grant, Nevada achieves similar leadership capability.
For UNLV, the grant is part of an expected major build-out in health sciences over the next five years and supports the university's goal to attain status as a Tier 1 institution.
"Our region must improve the quality of healthcare available to all Nevadans, and we have an incredible opportunity through this grant to build clinical and related research capacity in Southern Nevada and across the Mountain West," said UNLV President Neal Smatresk. "This program will allow UNLV and our partners to more readily support the rapid growth of medical advancements by teaming up to solve the unique health issues affecting our region."
Grant funding comes from the NIH Institutional Development Award (IDeA) Program. I
|Contact: Tony Allen|
University of Nevada, Las Vegas